KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $230.0 million.

  • Gilead Sciences' Share-based Compensation rose 648.15% to $230.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $886.0 million, marking a year-over-year increase of 884.52%. This contributed to the annual value of $835.0 million for FY2024, which is 900.78% up from last year.
  • Gilead Sciences' Share-based Compensation amounted to $230.0 million in Q3 2025, which was up 648.15% from $225.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Share-based Compensation registered a high of $230.0 million during Q3 2025, and its lowest value of $130.0 million during Q1 2022.
  • In the last 5 years, Gilead Sciences' Share-based Compensation had a median value of $187.0 million in 2024 and averaged $186.2 million.
  • As far as peak fluctuations go, Gilead Sciences' Share-based Compensation tumbled by 647.48% in 2022, and later skyrocketed by 2692.31% in 2023.
  • Over the past 5 years, Gilead Sciences' Share-based Compensation (Quarter) stood at $159.0 million in 2021, then grew by 9.43% to $174.0 million in 2022, then rose by 15.52% to $201.0 million in 2023, then increased by 10.45% to $222.0 million in 2024, then grew by 3.6% to $230.0 million in 2025.
  • Its Share-based Compensation stands at $230.0 million for Q3 2025, versus $225.0 million for Q2 2025 and $209.0 million for Q1 2025.